InvestorsHub Logo
Followers 13
Posts 2195
Boards Moderated 0
Alias Born 05/30/2012

Re: BBalls-N-CowTown post# 164988

Thursday, 05/13/2021 1:54:13 AM

Thursday, May 13, 2021 1:54:13 AM

Post# of 232977
I was in a stock last summer MBRX Moleculin Biotech that was also looking at a 2-DG treatment for Covid19.

They have a Prodrug called WP1122 that is a precursor to 2-DG and this supposedly enables it to stay in the body longer and be absorbed more completely. It was developed for applications in Cancer at MD Anderson.

They are planning a Phase 1 trial with the MHRA this summer. So they are pretty far out in the Trial stage.

Their in-vitro studies were showing a very high blockage rate ( 100% ) for Covid cell replication.

They theorize this process will work with all Corona Viruses, Rhinovirus, Herpes Virus. If true, they have a cure for the common cold.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News